Cell based therapy for duchenne muscular dystrophy

Andrea Farini, Paola Razini, Silvia Erratico, Yvan Torrente, Mirella Meregalli

Research output: Contribution to journalArticle

Abstract

Mutations in the dystrophin gene cause an X-linked genetic disorder: Duchenne muscular dystrophy (DMD). Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic stem cells and their possible use to treat DMD. The identification of a stem cell population providing efficient muscle regeneration is critical for the progression of cell therapy for DMD. We speculated that the most promising possibility for the treatment of DMD is a combination of different approaches, such as gene and stem cell therapy.

Original languageEnglish
Pages (from-to)526-534
Number of pages9
JournalJournal of Cellular Physiology
Volume221
Issue number3
DOIs
Publication statusPublished - Dec 2009

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Fingerprint Dive into the research topics of 'Cell based therapy for duchenne muscular dystrophy'. Together they form a unique fingerprint.

Cite this